Cargando…

Primary squamous cell carcinoma of the ovary. Review of the literature

Pure primary ovarian squamous cell carcinoma (oSCC) is very rare, with about 42 cases have been reported in the literature. Lacking effective treatment guidelines, the prognosis of oSCC is extremely poor. Here, we report a 52-year-old postmenopausal woman diagnosed with pure primary oSCC in our cent...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yan, Bian, Ce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515541/
https://www.ncbi.nlm.nih.gov/pubmed/36185237
http://dx.doi.org/10.3389/fonc.2022.962613
_version_ 1784798506229170176
author Luo, Yan
Bian, Ce
author_facet Luo, Yan
Bian, Ce
author_sort Luo, Yan
collection PubMed
description Pure primary ovarian squamous cell carcinoma (oSCC) is very rare, with about 42 cases have been reported in the literature. Lacking effective treatment guidelines, the prognosis of oSCC is extremely poor. Here, we report a 52-year-old postmenopausal woman diagnosed with pure primary oSCC in our center. The patient received debulking surgery followed by chemotherapy with carboplatin, paclitaxel, and bevacizumab. The patient survived 11 months after surgery and died of tumor progression and multiple organ failure. We also present a review of the literature.
format Online
Article
Text
id pubmed-9515541
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95155412022-09-29 Primary squamous cell carcinoma of the ovary. Review of the literature Luo, Yan Bian, Ce Front Oncol Oncology Pure primary ovarian squamous cell carcinoma (oSCC) is very rare, with about 42 cases have been reported in the literature. Lacking effective treatment guidelines, the prognosis of oSCC is extremely poor. Here, we report a 52-year-old postmenopausal woman diagnosed with pure primary oSCC in our center. The patient received debulking surgery followed by chemotherapy with carboplatin, paclitaxel, and bevacizumab. The patient survived 11 months after surgery and died of tumor progression and multiple organ failure. We also present a review of the literature. Frontiers Media S.A. 2022-09-14 /pmc/articles/PMC9515541/ /pubmed/36185237 http://dx.doi.org/10.3389/fonc.2022.962613 Text en Copyright © 2022 Luo and Bian https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Luo, Yan
Bian, Ce
Primary squamous cell carcinoma of the ovary. Review of the literature
title Primary squamous cell carcinoma of the ovary. Review of the literature
title_full Primary squamous cell carcinoma of the ovary. Review of the literature
title_fullStr Primary squamous cell carcinoma of the ovary. Review of the literature
title_full_unstemmed Primary squamous cell carcinoma of the ovary. Review of the literature
title_short Primary squamous cell carcinoma of the ovary. Review of the literature
title_sort primary squamous cell carcinoma of the ovary. review of the literature
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515541/
https://www.ncbi.nlm.nih.gov/pubmed/36185237
http://dx.doi.org/10.3389/fonc.2022.962613
work_keys_str_mv AT luoyan primarysquamouscellcarcinomaoftheovaryreviewoftheliterature
AT biance primarysquamouscellcarcinomaoftheovaryreviewoftheliterature